Wegovy major changes for patients

The approval comes as the demand for GLP-1 drugs continues to surge, with major pharmaceutical companies like Novo Nordisk and Eli Lilly racing to expand their production capacity.

A new study has also identified unreported side effects of weight-loss jabs, including fatigue and menstrual changes, which were not seen in initial clinical trials.

Researchers used AI to analyze hundreds of thousands of social media posts to uncover these patterns, suggesting a need for further investigation.

Meanwhile, some U.S. states have begun dropping Medicaid coverage for the drugs as costs mount, despite warnings that obesity-related health expenses will ultimately be higher.